Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Digital Biomarkers Companies

ID: MRFR/HC/10766-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025

Digital biomarkers companies specialize in leveraging digital technologies, wearables, and data analytics to capture and analyze physiological and behavioral markers for health conditions. These companies contribute to digital health and healthcare innovation by providing tools for remote monitoring, early disease detection, and personalized health management.

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Digital Biomarkers Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)22.6%
2024 Market Size$ 4.66 Billion
2025 Market Size$ 5.71 Billion
2035 Market Size$ 43.83 Billion

Key Players

Companies such as Apple Inc.
 Google LLC
Fitbit Inc.
Samsung Electronics
Roche Holding AG
Novartis AG
Opportunities
  • Integration of Big Data Analytics
  • Regulatory Support and Frameworks
  • Advancements in Wearable Technology

Top Industry Leaders in the Digital Biomarkers Market

Digital biomarkers Key Companies
Latest Digital Biomarkers Companies Update

Apple and Samsung unveiled new features in their smartwatches and health platforms for tracking sleep, stress, and other physiological parameters, expanding their digital biomarker offerings.

Verily Life Sciences (Alphabet) launched a new study using wearable sensors and AI to predict individual's risk of developing diabetes, showcasing the potential of digital biomarkers for early disease detection.

Akili Interactive Labs secured FDA approval for their digital biomarker test for cognitive decline, marking a significant step in the use of digital tools for mental health assessments.

Biofourmis announced a partnership with a major pharmaceutical company to use their AI-powered platform for analyzing wearable sensor data in clinical trials, improving research efficiency and drug development timelines.

AliveCor received breakthrough designation from the FDA for their KardiaMobile ECG device for detecting atrial fibrillation, highlighting the potential of digital biomarkers for remote cardiac monitoring and preventative care.

List of Digital Biomarkers Key Companies in the Market

  • ActiGraph LLC
  • AliveCor Inc.
  • Koneksa
  • Altoida Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Empatica Inc.
  • Vivo Sense
  • IXICO plc
  • Adherium Limited
  • Neurotrack Technologies, Inc.
  • Aural Analytic
  • Huma
  • Sonde Health, Inc.